Prognostic Value of a Classification System for Iliofemoral Stenting in Patients with Chronic Venous Obstruction.
Houman Jalaie, Mohammad E Barbati, Long Piao...
https://pubmed.ncbi.nlm.nih.gov/39393577/Actively Recruiting
Led by Ain Shams University · Updated on 2026-08-13
20
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating outcomes of iliac vein stenting using dedicated venous stents for treating chronic venous ulcers caused by post-thrombotic syndrome PTS. PTS is a common complication of deep vein thrombosis DVT, occurring in up to 50% of patients with iliofemoral DVT within two years. Despite anticoagulation, some patients develop severe PTS, which can lead to venous ulcers due to chronic venous obstruction that impairs blood flow and raises venous pressure. Participants will receive standard care for venous ulcers including wound assessment, dressing, and compression therapy. They will also undergo an interventional procedure involving endovascular iliac vein recanalization and stenting using self-expanding venous stents placed under ultrasound guidance. After stenting, anticoagulation therapy with low-molecular-weight heparin followed by warfarin or rivaroxaban will be administered for at least one year. The study is a prospective single-arm cohort conducted over two years with six months follow-up. During the study, participants will have clinical evaluations at 7 days, 1, 3, 6, and 12 months after treatment. Assessments include venous ulcer healing, ulcer size and depth, time to complete healing, and changes in clinical severity and quality of life scores. Imaging with venous duplex ultrasound and computed tomography venography will monitor stent patency and detect any complications. The primary outcome is complete healing of venous ulcers by 12 months, with additional measures including time to healing, severity score changes, and ulcer recurrence.
CONDITIONS
Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chronic Post-thrombotic Venous Ulcers
N
Nancy salah Nancy Salah
N
Naglaa Fathy Naglaa Fathy
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ain Shams University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 years with 6 months follow-up
Participants receive endovascular iliac vein recanalization and placement of dedicated venous stents along with standard venous ulcer care and compression therapy.
Twice-weekly wound care visits and scheduled follow-ups at 7 days, 1, 3, 6, and 12 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Houman Jalaie, Mohammad E Barbati, Long Piao...
https://pubmed.ncbi.nlm.nih.gov/39393577/Chelsea P Pappas, Gaurav Lakhanpal, Richard Kennedy...
https://pubmed.ncbi.nlm.nih.gov/41921606/Fedor Lurie, Marc Passman, Mark Meisner...
https://pubmed.ncbi.nlm.nih.gov/32113854/Julie Wang, Elise Smeath, Hui Yin Lim...
https://pubmed.ncbi.nlm.nih.gov/37651058/William A Marston, Michael A Vasquez, Fedor Lurie...
https://pubmed.ncbi.nlm.nih.gov/26992578/Ain Shams University
Lead Sponsor